NCT04861389

Brief Summary

The transradial access (TRA) is currently the preferred approach for percutaneous coronary intervention (PCI). However, in patients with ACUTE ST-segment elevation myocardial infarction (STEMI) after emergency PCI, the high incidence of THE radial artery RAO limits the future choice of the radial artery for percutaneous intervention. The literature reported that distal transradial access (dTRA) significantly reduced RAO after elective PCI, but the application of dTRA in emergency PCI in STEMI has not been reported. We have completed 126 cases of dTRA undergoing emergency PCI after STEMI, which has been preliminarily confirmed to be safe and effective. A single-center, open, prospective, randomized controlled study is planned to compare the use of dTRA and TRA in emergency PCI in STEMI patients. The primary endpoint was the INCIDENCE of RAO within 24 hours after surgery. This clinical study verified that dTRA compared with TRA could reduce the RAO incidence of STEMI patients after emergency PCI. The project will explore a new artery approach to reduce RAO, and provide a basis for the selection of artery approach in STEMI emergency PCI patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
414

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 27, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
Last Updated

April 27, 2021

Status Verified

April 1, 2021

Enrollment Period

12 months

First QC Date

November 29, 2020

Last Update Submit

April 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The RAO incidence during hospitalization

    The incidence of radial artery occlusion during hospitalization

    7 days

Secondary Outcomes (5)

  • Puncture time

    During the intervention

  • Compression time

    4-24 hours

  • Puncture success rate

    During the intervention

  • Incidence of hematoma, finger numbness or pain during hospitalization

    7days

  • Incidence of RAO at 1 and 6 months after surgery

    1 and 6 months

Study Arms (2)

Distal transradial access (dTRA)

EXPERIMENTAL

Distal transradial access for primary percutaneous coronary intervention in STEMI patients

Procedure: Arterial access

Transradial access (TRA)

ACTIVE COMPARATOR

Transradial access for primary percutaneous coronary intervention in STEMI patients

Procedure: Arterial access

Interventions

Arterial access for primary percutaneous coronary intervention in STEMI patients

Distal transradial access (dTRA)Transradial access (TRA)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of STEMI
  • To undergo emergency PCI treatment
  • Palpable pulsation of the radial artery and distal radial artery

You may not qualify if:

  • Arteriovenous fistula of radial artery and cephalic vein has been performed with regular hemodialysis
  • Suspicious left main block of electrocardiogram
  • Had used the radial artery percutaneous interventional treatment before
  • Cardiogenic shock

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shenzhen People's Hospital

Shenzhen, Guangdong, 518020, China

RECRUITING

MeSH Terms

Conditions

ST Elevation Myocardial InfarctionArterial Occlusive Diseases

Interventions

Vascular Access Devices

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

CathetersEquipment and Supplies

Study Officials

  • Shaohong Dong, MD

    Shenzhen People's Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2020

First Posted

April 27, 2021

Study Start

January 1, 2021

Primary Completion

December 31, 2021

Study Completion

January 31, 2022

Last Updated

April 27, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations